---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-033758"
form_type: "8-K"
ticker: "QNCX"
cik: "0001662774"
company_name: "Quince Therapeutics, Inc."
filed_at: "2026-02-02T23:59:59+00:00"
generated_at: "2026-05-16T05:37:13.040618+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Five directors resign from Quince Therapeutics board effective immediately

## Summary
- Directors Rajiv Patni, Luca Benatti, Margi McLoughlin, Una Ryan, and June Bray resigned on Jan 30, 2026.
- Resignations were not due to any disagreement with the company on operations, policies, or practices.
- CEO Dirk Thye remains as the sole executive officer; no replacements announced.
- Company continues under current management; board size reduced from six to one.

## SEC filing metadata
- accession: 0001193125-26-033758
- form_type: 8-K
- ticker: QNCX
- cik: 0001662774
- company_name: Quince Therapeutics, Inc.
- filed_at: 2026-02-02T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662774/000119312526033758/0001193125-26-033758-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662774/000119312526033758/d52597d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-033758
- JSON: https://secwatch.observer/filing/0001193125-26-033758.json
- Plain text: https://secwatch.observer/filing/0001193125-26-033758.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.